Page last updated: 2024-10-16

bromide and Amyotrophic Lateral Sclerosis

bromide has been researched along with Amyotrophic Lateral Sclerosis in 1 studies

Bromides: Salts of hydrobromic acid, HBr, with the bromine atom in the 1- oxidation state. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prasad, A1
Raju, G1
Sivalingam, V1
Girdhar, A1
Verma, M1
Vats, A1
Taneja, V1
Prabusankar, G1
Patel, BK1

Other Studies

1 other study available for bromide and Amyotrophic Lateral Sclerosis

ArticleYear
An acridine derivative, [4,5-bis{(N-carboxy methyl imidazolium)methyl}acridine] dibromide, shows anti-TDP-43 aggregation effect in ALS disease models.
    Scientific reports, 2016, 12-21, Volume: 6

    Topics: Acridines; Amyloid; Amyotrophic Lateral Sclerosis; Bromides; Circular Dichroism; DNA-Binding Protein

2016